Evidence map›Paper›PMID 36581942›Full record

ArticleMolecular cancer2022

lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m

Jin Wang, Lirong Tan, Xueting Yu, Xiyuan Cao, Beibei Jia, Rui Chen, Jianxiang Li

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 105 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. The mCells · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. mInternational journal of molecular medicine · 2026
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. The mMolecular biomedicine · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jin Wang *School of Public Health, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Lirong Tan *School of Public Health, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Xueting YuSchool of Public Health, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Xiyuan CaoSchool of Public Health, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Beibei JiaSchool of Public Health, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China.
Rui ChenDepartment of Respiratory Medicine, The Second Affiliated Hospital of Soochow University, Suzhou Jiangsu, 215004, China. chenruigood@126.com.
Jianxiang LiSchool of Public Health, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, China. aljxcr@suda.edu.cn.ORCID 0000-0001-6674-7703
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleLung cancer is the most prevalent form of cancer and has a high mortality rate, making it a global public health concern. The N

methodsThe RNAs that were bound to the m

resultsThis study provided evidence that m

conclusionsZNRD1-AS1 serves an important function and has clinical relevance in lung cancer. In addition, the findings suggested that m

Indexed as

Lung NeoplasmsMicroRNAsRNA, Long NoncodingAnimalsCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticHumansIn Situ Hybridization, FluorescenceLungMiceMice, NudeRNA HelicasesTensinsZincMicroRNAsMIRN942 microRNA, humanRNA HelicasesRNA, Long NoncodingTensinsTNS1 protein, humanYTHDC2 protein, humanZincCigarette smokeImmune infiltrationlncRNA ZNRD1-AS1Lung cancerm6A RNA methylationmiR-942TNS1

Identifiers

PMID36581942
PMCPMC9801573
OpenAlexW4313364715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.